Effect of prostate-specific membrane antigen on phospho-ERK, growth and migration of prostate cancer LNCaP cells
GUO Zheng-hui,HUANG Hai,DU Tao,XU Ke-wei,CAO Yi,CHEN Jie-qing,DONG Wen,YAO You-sheng,LIN Tian-xin,XIE Wen-lian,JIANG Chun,HAN Jin-li,HUANG Jian
DOI: https://doi.org/10.3969/j.issn.1000-4718.2011.06.009
2011-01-01
Abstract:AIM:To study the expression of prostate-specific membrane antigen(PSMA) on the level of phospho-ERK,cell growth and migration of prostate cancer LNCaP cells.METHODS: The method of silencing PSMA was established by lentivirus-mediated RNAi in our early experiment.The cells were divided into 3 groups.In experimental group,the expression of PSMA in LNCaP cells was stably blocked by lentivirus-mediated RNAi.In negative control group,the cells were transfected with lentivirus-mediated control RNAi(without any interference to PSMA).The normal LNCaP cells served as blank control.The cells in these 3 groups were cultured in both 2 environments: normal medium and medium with PD98059(an inhibitor of ERK phosphorylation).The phospho-ERK was detected by Western blotting and immunocytochemistry.Furthermore,the growth and migration of the cells were evaluated by MTT and transwell assays,respectively.RESULTS: In normal medium,the expression of phospho-ERK was attenuated in experimental group(P<0.05) and the quantity of "positive" cells was less than those in other 2 groups(P<0.05).Furthermore,the growth curves of the cells showed that the growth ability in experimental group was significantly decreased(P<0.05,after 48 h) and the migration ability in experimental group was reduced(P<0.05).In the inhibitory medium,the cells in all 3 groups expressed phospho-ERK at a lower level.Moreover,the abilities of growth and migration in these 3 groups were poorly displayed.These inhibitory effects on phosphorylation of ERK were similar to the cells in experimental group cultured in normal medium.CONCLUSION: PSMA may play a role in up-regulation of phospho-ERK and it may take an advantage in growth and migration of prostate cancer LNCaP cells.
What problem does this paper attempt to address?